Cintia Piccina, Chief Commercial Officer at Adaptimmune Therapeutics PLC (ADAP), sold 21,040 shares at $1.77 ($37K) on 2022-08-01, disclosed to the SEC on 2022-08-01.
Open-market sale of $37k ADAP by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ADAP | SELL | 2024-06-18 | $23K | — | Filing → |
| ADAP | SELL | 2023-01-31 | $22K | — | Filing → |